Atropine (MWI)
Welcome to the PulseAid listing for the Atropine drug offered from MWI. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | MWI |
NON-PROPRIETARY NAME: | Atropine Sulfate |
SUBSTANCE NAME: | ATROPINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-03-23 |
END MARKETING DATE: | 0000-00-00 |
Atropine HUMAN PRESCRIPTION DRUG Details:
Item Description | Atropine from MWI |
LABELER NAME: | MWI |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2015-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13985-606_dde94271-817f-4e0f-86e6-b138421201b3 |
PRODUCT NDC: | 13985-606 |
APPLICATION NUMBER: | NDA206289 |
Other ATROPINE SULFATE Pharmaceutical Manufacturers / Labelers: